http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8017654-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2786720cd363efcd84f5fd6492510e49 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C243-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C241-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C251-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C249-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D305-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-00 |
| filingDate | 2006-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4da9e375329c643cdd6a6a419cf18d1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f933e4c87a377242d908b8a2b66ce09 |
| publicationDate | 2011-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-8017654-B2 |
| titleOfInvention | Combination cancer therapy with bis(thiohydrazide) amide compounds |
| abstract | A method of treating a subject with cancer includes the step of co-administering to the subject over three to five weeks, a taxane in an amount of between about 243 μmol/m2 to 315 μmol/m2 (e.g., equivalent to paclitaxel in about 210-270 mg/m2); and a bis(thiohydrazide amide) in an amount between about 1473 μmol/m2 and about 1722 μmol/m2 (e.g., Compound (1) in about 590-690 mg/m2). The bis(thiohydrazide amide) is represented by Structural Formula (I), Y is a covalent bond or an optionally substituted straight chained hydrocarbyl group, or, Y, taken together with both >C=Z groups to which it is bonded, is an optionally substituted aromatic group. R 1 -R 4 are independently —H, an optionally substituted aliphatic group, an optionally substituted aryl group, or R 1 and R 3 taken together with the carbon and nitrogen atoms to which they are bonded, and/or R 2 and R 4 taken together with the carbon and nitrogen atoms to which they are bonded, form a non-aromatic heterocyclic ring optionally fused to an aromatic ring. R 7 -R 8 are independently —H, an optionally substituted aliphatic group, or an optionally substituted aryl group. Z is O or S. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013103795-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9156783-B2 |
| priorityDate | 2005-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 591.